Immunic (IMUX) Non Operating Income (2013 - 2026)

Immunic has disclosed Non Operating Income across 14 years of filings, most recently posting $647000.0 for Q1 2026.

• Non Operating Income for Q1 2026 came in at $647000.0, down 52.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.1 million (up 28.27% YoY), and the FY2025 annual result was $5.0 million, up 578.17% from the prior year.
• Non Operating Income came in at $647000.0 for Q1 2026 at Immunic, down from $3.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $4.3 million in Q4 2023 to a low of -$2.1 million in Q1 2024.
• The 5-year median for Non Operating Income is $627000.0 (2022), against an average of $689529.4.
• Across the five-year window, Non Operating Income slumped 205.81% in 2024 and surged 10962.96% in 2025, its largest moves.
• Immunic's Non Operating Income stood at $1.2 million in 2022, then jumped by 263.13% to $4.3 million in 2023, then plunged by 99.38% to $27000.0 in 2024, then soared by 10962.96% to $3.0 million in 2025, then plunged by 78.34% to $647000.0 in 2026.
• The last three Non Operating Income figures came in at $647000.0 (Q1 2026), $3.0 million (Q4 2025), and $414000.0 (Q3 2025), per Business Quant data.